5 Stock Gainers for Monday: Daqo New Energy, BioXcel, Livongo

Stocks rising Monday include Daqo New Energy, BioXcel Therapeutics, Peloton, Nantkwest and Altimmune.
Publish date:

Stocks finished higher on Monday as Amazon  (AMZN) - Get Report led the way, and coronavirus vaccine data from AstraZeneca  (AZN) - Get Report and Oxford University, published in the U.K. medical journal The Lancet, showed promise.

Here are some of the big movers in the stock market Monday:

1. Daqo New Energy | Percentage Increase Over 26%

The Street Quant Rates rate Daqo Energy a Buy with a rating score of B.

Daqo New Energy  (DQ) - Get Report, the Chinese maker of high-purity polysilicon for the global solar PV industry, recently said it planned to extend its access to China's capital markets. 

2. BioXcel Therapeutics | Percentage Increase Over 13%

BioXcel Therapeutics  (BTAI) - Get Report said Monday that a drug it was developing reduced agitation in patients with schizophrenia and bipolar disorder in two pivotal studies. 

3. Peloton Interactive | Percentage Increase Over 10%

Peloton Interactive  (PTON) - Get Report was climbing Monday after Goldman Sachs analysts raised their price target on the home-workout-technology company to a Wall-Street-high $84 a share from $66. 

4. Nantkwest | Percentage Increase Over 11%

The Street Quant Rating rates Nantkwest a Sell with a rating score of D.

Biotech Nantkwest  (NK) - Get Report recently announced the closing of a $90.7 million public stock offering. The company has signed a binding term sheet with ImmunityBio to develop vaccines and therapeutics for Covid-19.

5. Altimmune | Percentage Increase Over 11%

The Street Quant Rating rates Altimmune a Sell with a rating score of D.

Biopharm Altimmune  (ALT) - Get Report recently said it closed a $132 million public offering of common stock.